Reversible and Selective MAOIs in Combination with (S)SRIs: Risk of Serotonin Toxicity
MoclobemideAbstractTherapeutic doses of Moclobemide combined with any (S)SRI carries a significant risk of potentially fatal serotonin toxicity. This is made more unpredictable because multiple pharmaco-kinetic interactions via P-450 can come…